Cite
MLA Citation
M. Guo et al.. “2805 Overall survival gain with lenvatinib vs. placebo in radioactive iodine refractory differentiated thyroid cancer (RR-DTC): An updated analysis.” European journal of cancer, vol. 51, n.d., pp. S559–. http://access.bl.uk/ark:/81055/vdc_100030628283.0x00005c